25 related articles for article (PubMed ID: 30628674)
1. Enterolactone Induces G
Chikara S; Lindsey K; Dhillon H; Mamidi S; Kittilson J; Christofidou-Solomidou M; Reindl KM
Nutr Cancer; 2017; 69(4):652-662. PubMed ID: 28323486
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Biological Effect of Non-UV-Activated Bergapten on Selected Human Tumor Cells and the Insight into the Molecular Mechanism of Its Action.
Bartnik M; Sławińska-Brych A; Mizerska-Kowalska M; Zdzisińska B
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958539
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects.
Quetglas-Llabrés MM; Quispe C; Herrera-Bravo J; Catarino MD; Pereira OR; Cardoso SM; Dua K; Chellappan DK; Pabreja K; Satija S; Mehta M; Sureda A; Martorell M; Satmbekova D; Yeskaliyeva B; Sharifi-Rad J; Rasool N; Butnariu M; Bagiu IC; Bagiu RV; Calina D; Cho WC
Oxid Med Cell Longev; 2022; 2022():8615242. PubMed ID: 35509838
[TBL] [Abstract][Full Text] [Related]
4.
Ahmad A; Tiwari RK; Almeleebia TM; Al Fayi MS; Alshahrani MY; Ahmad I; Abohassan MS; Saeed M; Ansari IA
Saudi J Biol Sci; 2021 Nov; 28(11):6279-6288. PubMed ID: 34764752
[TBL] [Abstract][Full Text] [Related]
5. JAK2/STAT3‑mediated dose‑dependent cytostatic and cytotoxic effects of sesquiterpene lactones from
Keeratichamroen S; Lirdprapamongkol K; Thongnest S; Boonsombat J; Chawengrum P; Sornprachum T; Sirirak J; Verathamjamras C; Ornnork N; Ruchirawat S; Svasti J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738622
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Correction of Cisplatin-Induced Hemostatic Disorders.
Filonova MV; Fedorova EP; Churin AA; Kotlovskaya LY; Solov'ev MA; Udut VV
Bull Exp Biol Med; 2021 Mar; 170(5):623-626. PubMed ID: 33788113
[TBL] [Abstract][Full Text] [Related]
7. Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family.
Peruzzo R; Mattarei A; Azzolini M; Becker-Flegler KA; Romio M; Rigoni G; Carrer A; Biasutto L; Parrasia S; Kadow S; Managò A; Urbani A; Rossa A; Semenzato G; Soriano ME; Trentin L; Ahmad S; Edwards M; Gulbins E; Paradisi C; Zoratti M; Leanza L; Szabò I
Redox Biol; 2020 Oct; 37():101705. PubMed ID: 33007503
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects.
Ahmed S; Khan H; Aschner M; Mirzae H; Küpeli Akkol E; Capasso R
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781533
[TBL] [Abstract][Full Text] [Related]
9. Hesperidin induces apoptosis and G0/G1 arrest in human non-small cell lung cancer A549 cells.
Xia R; Sheng X; Xu X; Yu C; Lu H
Int J Mol Med; 2018 Jan; 41(1):464-472. PubMed ID: 29138795
[TBL] [Abstract][Full Text] [Related]
10. Bergapten: A review of its pharmacology, pharmacokinetics, and toxicity.
Liang Y; Xie L; Liu K; Cao Y; Dai X; Wang X; Lu J; Zhang X; Li X
Phytother Res; 2021 Nov; 35(11):6131-6147. PubMed ID: 34347307
[TBL] [Abstract][Full Text] [Related]
11. Bergapten induces G1 arrest of non‑small cell lung cancer cells, associated with the p53‑mediated cascade.
Chiang SR; Lin CS; Lin HH; Shieh PC; Kao SH
Mol Med Rep; 2019 Mar; 19(3):1972-1978. PubMed ID: 30628674
[TBL] [Abstract][Full Text] [Related]
12. Bergapten induces G1 arrest and pro-apoptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis.
Lin CP; Lin CS; Lin HH; Li KT; Kao SH; Tsao SM
Environ Toxicol; 2019 Mar; 34(3):303-311. PubMed ID: 30576070
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
[TBL] [Abstract][Full Text] [Related]
14. JS‑K induces G2/M phase cell cycle arrest and apoptosis in A549 and H460 cells via the p53/p21WAF1/CIP1 and p27KIP1 pathways.
Song Z; Yin Y; Hao S; Wei J; Liu B; Huang X; Gao C; Zhu R; Liao W; Cai D
Oncol Rep; 2019 Jun; 41(6):3475-3487. PubMed ID: 31002373
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
